Holly B. Kordasiewicz, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 4,141 shares at $75.66 ($313K) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Open-market sale of $313k IONS by EVP, Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |